20934-81-0

Basic information

• Product Name: 4-BENZOOXAZOL-2-YL-PHENYLAMINE
• Synonyms: ASISCHEM T30955;CHEMBRDG-BB 4101678;LABOTEST-BB LT00133884;4-(BENZO[D]OXAZOL-2-YL)ANILINE;4-BENZOOXAZOL-2-YL-PHENYLAMINE;4-(1,3-BENZOXAZOL-2-YL)PHENYLAMINE;4-(1,3-BENZOXAZOL-2-YL)ANILINE;AKOS BB-8497
• CAS NO: 20934-81-0
• Molecular Formula: C₁₃H₁₀N₂O
• Molecular Weight: 210.23
• EINECS: 200-258-5
• Mol File: 20934-81-0.mol
• Article Data: 50

Chemical Properties

• Melting Point: 169-170 °C
• Boiling Point: 361.4°Cat760mmHg
• Flash Point: 172.4°C
• Appearance: /
• Density: 1.257g/cm³
• Vapor Pressure: 2.08E-05mmHg at 25°C
• Refractive Index: 1.682
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.29±0.10(Predicted)
• CAS DataBase Reference: 4-BENZOOXAZOL-2-YL-PHENYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZOOXAZOL-2-YL-PHENYLAMINE(20934-81-0)
• EPA Substance Registry System: 4-BENZOOXAZOL-2-YL-PHENYLAMINE(20934-81-0)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 20934-81-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C13H10N2O/c14-10-7-5-9(6-8-10)13-15-11-3-1-2-4-12(11)16-13/h1-8H,14H2

Upstream product

• 27337-45-7 N-(4-(benzo[d]oxazol-2-yl)phenyl)acetamide 
• 4755-50-4 4-(dimethylamino)benzoyl chloride 
• 614-70-0 2-ethylaminophenol 
• 150-13-0 4-amino-benzoic acid 
• 95-55-6 2-amino-phenol 
• 273-53-0 benzoxazole 
• 106-40-1 4-bromo-aniline 
• 16106-38-0 4-aminobenzoyl chloride 
• 615-36-1 2-bromoaniline 
• 873-74-5 4-Aminobenzonitrile 
• 556-18-3 4-aminobenzaldehyde 
• 455-14-1 4-trifluoromethylphenylamine 
• 109-86-4 2-methoxy-ethanol 
• 840-58-4 2(4-nitrophenyl)benzoxazole 

Downstream Products

• 16707-39-4 N-(4-benzooxazol-2-yl-phenyl)-succinamic acid 
• 100476-59-3 3-benzoxazolin-2-one 
• 100476-58-2 3-benzothiazoline-2-thinone 
• 29754-17-4 2-(p-benzamidophenyl)benzoxazole 
• 132194-99-1 bis(o-nitrobenzyl) 2,5-bis<carbamoyl>terephthalate 
• 162374-61-0 -(4′-azidophenyl)benzoxazole 
• 27337-45-7 N-(4-(benzo[d]oxazol-2-yl)phenyl)acetamide 
• 733038-35-2 2-(4-amino-3-bromophenyl)benzoxazole 
• 1346233-01-9 C₂₄H₂₃N₃O 
• 1617494-80-0 C₂₀H₁₄N₂O₂ 
• 1617494-82-2 2- [[[4-(2-benzoxazolyl)phenyl]imino]-methyl]-5-(diethylamino)-phenol 

Relevant articles and documents

Biological evaluation of hepatitis C virus helicase inhibitors

A small chemical library has been synthesized and assayed for inhibition of HCV helicase activity. This study provides the structure-activity relationship of the reported inhibitors, with emphasis placed on the aminophenylbenzimidazole moiety and the link

Crystal structures of benzoxazolyl-copper(iii,ii,i) complexes and investigation of Cu(ii)-mediated aryl carbon-hydrogen bromination

Copper complexes have been frequently involved in many Cu-mediated carbon-hydrogen halogenation reactions. We fortunately obtained three different valence benzoxazolyl-copper complexes, along with aryl carbon-hydrogen bromination, in the self-assembly reaction of ligands with CuBr2. The complexes have been successfully characterized by X-ray single crystal diffraction analyses. The results indicate that 1 consists of di-brominated p-benzoxazolylphenylamine (L) and an unusual high valence copper(iii) complex with tetrahedral geometry, 2 is the first polymeric catenulate di-brominated benzoxazolyl-copper(i) complex and 3 is the mono-brominated benzoxazolyl-copper(ii) complex. We speculate proposed mechanisms for the formation of these complexes and the bromination of aryl carbon-hydrogen based on these crystal structures. This journal is

Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory

Based on the Gaussian-based quantitative structure-activity relationship (QSAR) and virtual screening (VS) processes, some promising acetylcholinesterase inhibitors (AChEIs) having antioxidant potential were designed synthesized, characterized, and evalua

A Multi-step Virtual Screening Protocol for the Identification of Novel Non-acidic Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors

Microsomal prostaglandin E2 synthase-1 (mPGES-1) is a potential therapeutic target for the treatment of inflammatory diseases and certain types of cancer. To identify novel scaffolds for mPGES-1 inhibition, we applied a virtual screening (VS) p

Tertiary amine derivatives and organic electroluminescent device including the same

A UV-region high-energy external light source is effectively absorbed to minimize damage to organic materials in the organic electroluminescent device. 1 Is a cross-sectional view of an organic electroluminescence device according to the present invention. O-2 electrode 1 Or more organic material layers disposed between the (2) and (1) th electrodes. A capping layer is included. The organic material layer and/or the capping layer may include the 1 st amine derivative represented by Formula 3. Chemical Formula 1. Wherein each substituent in Formula 1 is as defined in the description of the invention.

An electroluminescent compound and an electroluminescent device comprising the same

The present invention relates to an organic light emitting compound and an organic light emitting device employing the same, wherein the organic light emitting compound has excellent solubility in an organic solvent, thereby enabling a solution process during device manufacturing, and improving light emitting characteristics such as low voltage driving, luminous efficiency, long lifespan, etc. The present invention provides the organic light emitting compound represented by chemical formula I and capable of applying the solution process by having crosslinking properties.

COMPOSITIONS AND METHODS FOR TREATING CANCER

This invention is directed to compositions and methods for treating cancer in a patient.